Published by Coherent Market Insights
Posted on September 22, 2021
Computational biology is one of the most rapidly advancing areas in all of biology. It combines principles from genomics, cellular biology, computer science, information science, and medicine and it contributes to advances in many areas of biology. Computational Biology includes the study and research of complex biological systems, the design and manipulation of complex systems, the analysis and measurement of complex biological functions, and the applications to these systems of various scientific disciplines. Computational Biology is the fastest growing area of scientific research and has a significant impact on advances in all areas of biology and medical research. Computational Biology employs techniques from physics, computer science, mathematics, and software engineering to study living things and systems at various scales from the single-cell up to human organs and muscles.
The global computational biology market was valued at US$ 3,453.2 Mn in 2020 and is forecast to reach a value of US$ 12,601.1 Mn by 2028 at a CAGR of 17.6% between 2021 and 2028.
Request sample copy of this report:
https://www.coherentmarketinsights.com/insight/request-sample/3915
Key factors driving the growth of the computational biology market are the rise in demand for predictive models, increasing application in human genome projects, and growing R &D for drug discovery. A growing number of clinical studies in pharmacogenomics and pharmacokinetics and growth in bioinformatics research has also augmented the growth of the computational biology market. The rise in research funding in bioinformatics is leading to more advancement in the field of computational biology. For instance, The National Institutes of Health is the largest public funder of biomedical research in the world, with 24 institutes and centers awarding $32 billion a year in grants to improve human life and reduce illness and disability.
Key Developments:
In May 2020, Evogene Ltd. a computational biology company targeting to revolutionize life-science product development across several market segments, announces it’s rebranding
In March 2021, ALSA Ventures announced the launch of Promatix Inc., a Delaware incorporated company, to develop novel therapeutics with the potential to transform the treatment of cancer. Promatix will use its multi-omic proprietary database, TxPro, to mine for a novel, and validate existing, drug targets.
Key Players In Computational Biology Market
The “Global Computational Biology Market” study report will provide a valuable insight with an emphasis on the global market. The major players in the market are Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc.
In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Note: Access insightful study with over 150+ pages, list of tables & figures, profiling 20+ companies.
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Computational Biology Market to reach a value of US$ 12,601.1 Mn by 2028 at a CAGR of 17.6% during the forecast period 2021 – 2028 appeared first on Gatorledger.
Computational biology is one of the most rapidly advancing areas in all of biology. It combines principles from genomics, cellular biology, computer science, information science, and medicine and it contributes to advances in many areas of biology. Computational Biology includes the study and research of complex biological systems, the design and manipulation of complex systems, the analysis and measurement of complex biological functions, and the applications to these systems of various scientific disciplines. Computational Biology is the fastest growing area of scientific research and has a significant impact on advances in all areas of biology and medical research. Computational Biology employs techniques from physics, computer science, mathematics, and software engineering to study living things and systems at various scales from the single-cell up to human organs and muscles.
The global computational biology market was valued at US$ 3,453.2 Mn in 2020 and is forecast to reach a value of US$ 12,601.1 Mn by 2028 at a CAGR of 17.6% between 2021 and 2028.
Request sample copy of this report:
https://www.coherentmarketinsights.com/insight/request-sample/3915
Key factors driving the growth of the computational biology market are the rise in demand for predictive models, increasing application in human genome projects, and growing R &D for drug discovery. A growing number of clinical studies in pharmacogenomics and pharmacokinetics and growth in bioinformatics research has also augmented the growth of the computational biology market. The rise in research funding in bioinformatics is leading to more advancement in the field of computational biology. For instance, The National Institutes of Health is the largest public funder of biomedical research in the world, with 24 institutes and centers awarding $32 billion a year in grants to improve human life and reduce illness and disability.
Key Developments:
In May 2020, Evogene Ltd. a computational biology company targeting to revolutionize life-science product development across several market segments, announces it’s rebranding
In March 2021, ALSA Ventures announced the launch of Promatix Inc., a Delaware incorporated company, to develop novel therapeutics with the potential to transform the treatment of cancer. Promatix will use its multi-omic proprietary database, TxPro, to mine for a novel, and validate existing, drug targets.
Key Players In Computational Biology Market
The “Global Computational Biology Market” study report will provide a valuable insight with an emphasis on the global market. The major players in the market are Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc.
In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Note: Access insightful study with over 150+ pages, list of tables & figures, profiling 20+ companies.
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Computational Biology Market to reach a value of US$ 12,601.1 Mn by 2028 at a CAGR of 17.6% during the forecast period 2021 – 2028 appeared first on Gatorledger.
Explore more articles in the Research Reports category
